STATE OF WISCONSIN
Controlled Substances Board
IN THE MATTER OF RULE-MAKING PROCEEDINGS BEFORE THE
CONTROLLED SUBSTANCES BOARD
AFFIRMATIVE ACTION ORDER
OF THE CONTROLLED SUBSTANCES BOARD
FINDINGS
1. On March 1, 2017, the Department of Justice, Drug Enforcement Administration published its final rule in the Federal Register placing 4-MePPP and a-PBP into schedule I of the federal Controlled Substances Act. The scheduling action is effective March 1, 2017.
2. The Controlled Substances Board did not receive an objection to similarly treating 4-MePPP and a-PBP as schedule I under ch. 961, Stats. within 30 days of the date of publication in the federal register of the final order designating 4-MePPP and a-PBP as controlled substances. 3. The Controlled Substances Board will promulgate a final rule, without making the determinations or findings required by ss. 961.11(1), (1m), (1r) and (2) or s. 961.19 and omitting the notice of proposed rule making, designating 4-MePPP and a-PBP as schedule I controlled substances. ORDER
Pursuant to s. 961.11(4), Stats., the Controlled Substances Board by affirmative action similarly treats 4-MePPP and a-PBP under chapter 961, Stats. by creating the following: CSB 2.52 Addition of 4-MePPP and a-PBP to schedule I. Section 961.14(7)(L)32. and 33., Stats., is created to read: 961.14(7)(L)32. 4-methyl-alpha-pyrrolidinopropiophenone, commonly known as 4-MePPP.
33. Alpha-pyrrolidinobutiophenone, commonly known as a-PBP.
This order shall take effect on April 10, 2017 to allow for publication in the Administrative Register. The order expires upon promulgation of a final rule.
Dated April 4, 2017 
Doug Englebert, Chair
Controlled Substances Board
